Inhibition of protein translation as a novel mechanism for prostaglandin E2 regulation of cell functions

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 56-66

  Okunishi, Katsuhide ^a,b   DeGraaf, Angela J ^a   Zaslona, Zbigniew ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Fibroblasts; Macrophages; Mammalian target of rapamycin; Protein kinase A; Ribosomal protein S6

Indexed keywords

COLLAGEN TYPE 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PROCOLLAGEN; PROSTAGLANDIN E2; PROTEIN S6; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ADULT; ANIMAL CELL; ARTICLE; CELL FUNCTION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; TRANSLATION REGULATION; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; FIBROBLAST; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG; MACROPHAGE; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; RNA INTERFERENCE;

FIBROBLASTS; MACROPHAGES; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE A; RIBOSOMAL PROTEIN S6;

ANIMALS; CELL LINE; COLLAGEN TYPE I; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; FIBROBLASTS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; RIBOSOMAL PROTEIN S6; RNA INTERFERENCE; TOR SERINE-THREONINE KINASES;

EID: 84894594276     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-231720     Document Type: Article

References (50)

1. Wynn, T. A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529
2. Hetzel, M., Bachem, M., Anders, D., Trischler, G., and Faehling, M. (2005) Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 183, 225-237
3. Elias, J. A., Rossman, M. D., Zurier, R. B., and Daniele, R. P. (1985) Human alveolar macrophage inhibition of lung fibroblast growth: a prostaglandin-dependent process. Am. Rev. Respir. Dis. 131, 94-99
4. Bitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S., and Crystal, R. G. (1986) Modulation of alveolar macrophagedriven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 77, 700-708
5. Fine, A., Poliks, C. F., Donahue, L. P., Smith, B. D., and Goldstein, R. H. (1989) The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. J. Biol. Chem. 264, 16988-16991
6. Kohyama, T., Ertl, R. F., Valenti, V., Spurzem, J., Kawamoto, M., Nakamura, Y., Veys, T., Allegra, L., Romberger, D., and Rennard, S. I. (2001) Prostaglandin E(2) inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1257-L1263
7. Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., and Moore, B. B. (2003) Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 29, 537-544
8. White, E. S., Atrasz, R. G., Dickie, E. G., Aronoff, D. M., Stambolic, V., Mak, T. W., Moore, B. B., and Peters-Golden, M. (2005) Prostaglandin E(2) inhibits fibroblast migration by Eprostanoid 2 receptor-mediated increase in PTEN activity. Am. J. Respir. Cell Mol. Biol. 32, 135-141
9. Huang, S., Wettlaufer, S. H., Hogaboam, C., Aronoff, D. M., and Peters-Golden, M. (2007) Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L405-413
10. Huang, S. K., Wettlaufer, S. H., Chung, J., and Peters-Golden, M. (2008) Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. Am. J. Respir. Cell Mol. Biol. 39, 482-489
11. Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., and Peters-Golden, M. (2009) Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 23, 4317-4326
12. Huang, S. K., Scruggs, A. M., Donaghy, J., McEachin, R. C., Fisher, A. S., Richardson, B. C., and Peters-Golden, M. (2012) Prostaglandin E2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J. 26, 3703-3714
13. Borok, Z., Gillissen, A., Buhl, R., Hoyt, R., Hubbard, R., Ozaki, T., Rennard, S., and Crystal, R. (1991) Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am. Rev. Respir. Dis. 144, 1080-1084
14. Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., and Peters-Golden, M. (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesized prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95, 1861-1868
15. Fine, A., Matsui, R., Zhan, X., Poliks, C. F., Smith, B. D., and Goldstein, R. H. (1992) Discordant regulation of human type I collagen genes by prostaglandin E2. Biochim. Biophys. Acta 1135, 67-72
16. Liu, X., Ostrom, R. S., and Insel, P. A. (2004) cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am. J. Physiol. Cell Physiol. 286, C1089-1099
17. Zhu Y., Liu X., Sköld C. M., Wang H., Kohyama T., Wen F. Q., Ertl, R. F., and Rennard, S. I. (2001) Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir. Res. 2, 300-305
18. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
19. Ruvinsky, I., and Meyuhas, O. (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348
20. Meyuhas, O., and Dreazen, A. (2009) Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog. Mol. Biol. Transl. Sci. 90, 109-153
21. Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., Stoolman, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., Towes, G. B., Sisson, T. H., Moore, B. B., and Peters-Golden, M. (2010) The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 120, 1950-1960
22. Canetti, C., Aronoff, D. M., Choe, M., Flamand, N., Wettlaufer, S., Toews, G. B., Chen, G. H., and Peters-Golden, M. (2006) Differential regulation by leukotrienes and calcium of Fc receptor-induced phagocytosis and Syk activation in dendritic cells versus macrophages. J. Leukoc. Biol. 79, 1234-1241
23. Poulalhon, N., Farge, D., Roos, N., Tacheau, C., Neuzillet, C., Michel, L., Mauviel, A., and Verrecchia, F. (2006) Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin: a direct role as an antifibrotic agent? J. Biol. Chem. 281, 33045-33052
24. Serezani, C. H., Aronoff, D. M., Jancar, S., Mancuso, P., and Peters-Golden, M. (2005) Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106, 1067-1075
25. Jensen, L. T., and Høst, N. B. (1997) Collagen: scaffold for repair or execution. Cardiovasc. Res. 33, 535-539
26. Hulmes, D. J. (2002) Building collagen molecules, fibrils, and suprafibrillar structures. J. Struct. Biol. 137, 2-10
27. Gilroy, D. W., Saunders, M. A., and Wu, K. K. (2001) COX-2 expression and cell cycle progression in human fibroblasts. Am. J. Physiol. Cell Physiol. 281, C188-C194
28. af Forselles, K. J., Root, J., Clarke, T., Davey, D., Aughton, K., Dack, K., and Pullen, N. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist. (2011) Br. J. Pharmacol. 164, 1847-1856
29. Rennard, S.I., Stier, L.E., and Crystal, R.G. (1982) Intracellular degradation of newly synthesized collagen. J. Invest. Dermatol. 79(Suppl 1), 77S-82S.
30. Laurent, G. J. (1987) Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am. J. Physiol. 252, C1-C9
31. Tanaka, T., Yoshimi, M., Maeyama, T., Hagimoto, N., Kuwano, K., and Hara, N. (2002) Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur. Respir. J. 20, 359-368
32. Gordon, S. (2007) The macrophage: past, present and future. Eur. J. Immunol. 37(Suppl 1), S9-S17
33. Peters-Golden, M. (2009) Putting on the brakes: cyclic AMP as a multipronged controller of macrophage function. Sci. Signal. 2, pe37
34. Kalinski, P. (2012) Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21-28
35. Moore, C. E., Xie, J., Gomez, E., and Herbert, T. P. (2009) Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J. Mol. Biol. 389, 480-494
36. Misra, U. K., and Pizzo, S. V. (2009) Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades. J. Cell. Biochem. 108, 998-1011
37. Kim, H. W., Ha, S. H., Lee, M. N., Huston, E., Kim, D. H., Jang, S. K., Suh, P. G., Houslay, M. D., and Ryu, S. H. (2010) Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D. Mol. Cell. Biol. 30, 5406-5420
38. Scott, P. H., and Lawrence, J. C. Jr. (1998) Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes. J. Biol. Chem. 273, 34496-34501
39. Xie, J., Ponuwei, G. A., Moore, C. E., Willars, G. B., Tee, A. R., and Herbert, T. P. (2011) cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Cell. Signal. 23, 1927-1935
40. Mavrakis, M., Lippincott-Schwartz, J., Stratakis, C. A., and Bossis, I. (2006) Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum. Mol. Genet. 15, 2962-2971
41. Rocchi, S., Gaillard, I., van Obberghen, E., Chambaz, E. M., and Vilgrain, I. (2000) Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase. Biochem. J. 352(Pt 2), 483-490
42. Zito, C.I., Qin, H., Blenis, J., and Bennett, A. M. (2007) SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway. J. Biol. Chem. 282, 6946-6953
43. Larsson, O., Diebold, D., Fan, D., Peterson, M., Nho, R. S., Bitterman, P. B., and Henke, C. A. (2008) Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One 3, e3220
44. Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini, D. M. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113
45. Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., Wang, S., Ren, P., Martin, M., Jessen, K., Feldman, M. E., Weissman, J. S., Shokat, K. M., Rommel, C., and Ruggero, D. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55-61
46. Valdez, P. A., Vithayathil, P. J., Janelsins, B. M., Shaffer, A. L., and Williamson, P. R., and Datta, S. K. (2012) Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36, 668-679
47. Ji, R., Sanchez, C. M., Chou, C. L., Chen, X. B., Woodward, D. F., and Regan, J. W. (2012) Prostanoid EP1 receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMPindependent activation of protein kinase A, CREB and NF-B. Br. J. Pharmacol. 166, 1033-1046
48. Xia, D., Wang, D., Kim, S. H., Katoh, H., and DuBois, R. N. (2012) Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat. Med. 18, 224-226
49. Schweda, F., Klar, J., Narumiya, S., Nüsing, R. M., and Kurtz, A. (2004) Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am. J. Physiol. Renal Physiol. 287, F427-F433
50. Goc, A., Choudhary, M., Byzova, T. V., and Somanath, P. R. (2011) TGFbeta- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J. Cell. Physiol. 226, 3004-3013